{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Adicet Bio, Inc."},"Symbol":{"label":"Symbol","value":"ACET"},"Address":{"label":"Address","value":"200 CLARENDON STREET FLOOR 6, BOSTON, Massachusetts, 2116, United States"},"Phone":{"label":"Phone","value":"+1 650 503-9095"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients."},"CompanyUrl":{"label":"Company Url","value":"https://www.adicetbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Blake Aftab","title":"Chief Scientific Officer &amp; Senior Vice President"},{"name":"Donald Healey","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}